Nanoparticles in Targeted Drug Delivery System
Abstract
Nanotechnology has emerged as a transformative approach in modern pharmaceutical sciences, particularly in improving drug delivery system[1,3]. Nanoparticles, due to their unique physicochemical properties, enable targeted delivery of therapeutic agents to specific sites within the body. This thesis explores the principles, types, mechanisms, advantages, limitations, and applications of nanoparticles in targeted drug delivery. Special emphasis is placed on their role in enhancing bioavailability, reducing toxicity, and improving therapeutic efficacy [7,16]. The study also highlights recent advancements and future perspectives in nanomedicine.
Downloads
References
Allen TM, Cullis PR. Drug delivery systems: Entering the mainstream. Science. 2004;303(5665):1818–1822.
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751–760.
Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3(1):16–20.
Torchilin VP. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm. 2009;71(3):431–444.
Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov. 2003;2(5):347–360.
Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine. Clin Pharmacol Ther. 2008;83(5):761–769.
Patra JK, Das G, Fraceto LF, et al. Nano-based drug delivery systems. J Nanobiotechnol. 2018;16:71.
Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine. Nat Rev Cancer. 2017;17(1):20–37.
Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR. Nanoparticle-based medicines. Pharm Res. 2016;33(10):2373–2387.
Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Nanoparticle biodistribution. Mol Pharm. 2008;5(4):505–515.
Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers. Nat Mater. 2013;12(11):991–1003.
Lammers T, Kiessling F, Hennink WE, Storm G. Nanotheranostics. Mol Pharm. 2010;7(6):1899–1912.
Kulkarni JA, Witzigmann D, Chen S, Cullis PR. Lipid nanoparticle technology. Acc Chem Res. 2019;52(9):2435–2444.
Panyam J, Labhasetwar V. Biodegradable nanoparticles. Adv Drug Deliv Rev. 2003;55(3):329–347.
Couvreur P. Nanoparticles in drug delivery. Adv Drug Deliv Rev. 2013;65(1):21–23.
Parveen S, Misra R, Sahoo SK. Nanoparticles in therapeutics. Nanomedicine. 2012;8(2):147–166.
Wang AZ, Langer R, Farokhzad OC. Nanoparticle drug delivery. Annu Rev Med. 2012;63:185–198.
Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics. Nat Rev Drug Discov. 2008;7(9):771–782.
Sercombe L, Veerati T, Moheimani F, et al. Liposome drug delivery. Front Pharmacol. 2015;6:286.
Mitchell MJ, Billingsley MM, Haley RM, et al. Precision nanoparticles. Nat Rev Drug Discov. 2021;20(2):101–124.
Torchilin VP. Recent advances with liposomes. Nat Rev Drug Discov. 2005;4(2):145–160.
Jain KK. Nanomedicine: Application of nanobiotechnology. Pharm Res. 2008;25(3):533–549.
Brannon-Peppas L, Blanchette JO. Nanoparticle targeting strategies. Adv Drug Deliv Rev. 2004;56(11):1649–1659.
Maeda H, Bharate GY, Daruwalla J. EPR effect in tumors. Eur J Pharm Biopharm. 2009;71(3):409–419.
Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology. Nanomedicine. 2005;1(3):193–212.
Ferrari M. Cancer nanotechnology. Nat Rev Cancer. 2005;5(3):161–171.
Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles. Clin Cancer Res. 2008;14(5):1310–1316.
Singh R, Lillard JW. Nanoparticle toxicity. Exp Mol Pathol. 2009;86(3):215–223.
Albanese A, Tang PS, Chan WC. Nanoparticle cellular interactions. Annu Rev Biomed Eng. 2012;14:1–16.
Blanco E, Shen H, Ferrari M. Principles of nanoparticle design. Nat Biotechnol. 2015;33(9):941–951.
Petros RA, DeSimone JM. Strategies in nanomedicine. Nat Rev Drug Discov. 2010;9(8):615–627.
Zhao L, Seth A, Wibowo N, et al. Nanoparticle vaccines. Nanomedicine. 2014;9(5):673–689.
Shi Y, van der Meel R, Theek B, et al. Nanotechnology in cancer. Adv Drug Deliv Rev. 2020;160:78–104.
He Q, Shi J. MSN-based drug delivery. J Mater Chem. 2011;21:5845–5855.
Wang Y, Zhang L, Guo S. Nanoparticles in gene therapy. Biotechnol Adv. 2016;34(5):707–720.
Cheng CJ, Tietjen GT, Saucier-Sawyer JK, Saltzman WM. Nanoparticle drug delivery. Nat Rev Drug Discov. 2015;14(4):239–247.
Zhang YN, Poon W, Tavares AJ, et al. Nanoparticle–protein interactions. J Control Release. 2016;240:332–348.
Kamaly N, Yameen B, Wu J, Farokhzad OC. Targeted nanoparticles. Chem Rev. 2016;116(4):2602–2663.
Bae YH, Park K. Targeted drug delivery challenges. J Control Release. 2011;153(3):198–205.
Etheridge ML, Campbell SA, Erdman AG, et al. Nanomedicine future. Nanomedicine. 2013;9(1):1–14.
Published
How to Cite
Issue
Section
Copyright (c) 2026 Vaidehi Acharya, Hemadri Sharma
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
. 